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AKRİLAMİDİN HÜCRE İSKELET PROTEİNLERİ ÜZERİNE ETKİLERİ 
 
ÖZET 
 
Evrim sürecinde, hücrelerin ileri organizasyonu, tüm ökaryotik hücrelerin 
sitoplazmaları boyunca uzanan  protein filament ağından oluşan hücre iskeleti 
tarafından sağlanır. Hücre iskeleti hücre hareketlerinden ve sitoplazmanın genel 
organizasyonundan sorumludur. Mikrotübüller hücre iskeletinin major 
elementlerinden biridir. Mikrotübüller, globuler bir protein olan tübülinden oluşan 
uzun protein polimerleridir. Görevlerini tübülin alt birimlerinin polimerizasyonu ve 
depolimerizasyonuyla veya mikrotübül motor proteinlerinin hareketiyle yerine 
getirirler. Mikrotübüller ayrıca nöronal hücre iskeletinin major elementlerinden 
biridir ve aksonal transportta rolleri vardır. 
Akrilamid yüksek oranda suda çözünür olan bir ,-doymamış karbonil bileşenidir. 
Polimer üretimi, cevher işlenmesi, mineral işlenmesi, kozmetik katkılar gibi geniş bir 
endüstiriyel kullanım alanı vardır. Akrilamid nörotoksik olduğu kadar, genotoksik, 
karsinojenik, erkek üreme sistemi üzerine toksik etkileri olan bir maddedir. Santral-
periferal distal aksonopatiye neden olur. Bu aksonopatinin morfolojik belirteci 
preterminal distal sinirlerde multifokal paranodal şişkinlikler olarak başlayan akson 
dejenerasyonu olarak düşünülmektedir. Akrilamid nörotoksisitesinin semptomları 
ekstremitelerin güçsüzlüğü, kilo kaybı ve koordinasyonu bozulmuş yürümedir.  
Bu çalışmada, akrilamidin mikrotübüller üzerine in vitro etkileri farklı metodlar 
kullanarak araştırıldı. İlk olarak, tübülin proteinleri sığır beyninden tekrarlanan 
polimerizasyon ve depolimerizasyon döngüleri ve sonra iyon-değiştirici kolon 
kromatografisiyle saflaştırıldı. Akrilamidin mikrotübüller üzerine olan etkilerini 
göstermek için sedimentasyon, floresan spektrometre, malakayt yeşili yöntemi ve 
elektron mikroskopi teknikleri kullanıldı. Sedimentasyon deneyleri sırasında, tübülin 
farklı koşullarda akrilamide maruz bırakıldı ve bazı deneylerde taxol ile stabilize 
edilmiş mikrotübüller akrilamidle muamele edildi. Floresan spektrometre akrilamid 
varlığındaki mikrotübüllerin yapısal değişimlerini tübülin alt birimlerindeki içsel 
florofor triptofan kalıntıları yoluyla göstermek için kullanıldı. Mikrotübül 
polimerizasyonu sırasında oluşan Pi miktarları akrilamid varlığında malakayt yeşili 
kullanılarak ölçüldü. Buna ek olarak, sedimentasyon ve floresan spektrometre   
deneylerinde pellet olarak çöktürülen yapıları gözlemlemek için akrilamidle 
muamele edilmiş taxol ile stabilize mikrotübüller Transmisyon Elektron Mikroskopi 
ile incelendi.    
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EFFECTS OF ACRYLAMIDE ON CYTOSKELETAL PROTEINS 
 
SUMMARY 
 
A further level of organization of cells was provided by the cytoskeleton, which 
consists of a network of protein filaments extending throughout the cytoplasm of all 
eukaryotic cells. The cytoskeleton is responsible for cell movements and general 
organization of cytoplasm. Microtubules are one of the major elements of 
cytoskeleton. They are long protein polymers which are composed of a globular 
protein, tubulin. Microtubules perform their tasks by polymerization and 
depolymerization of tubulin subunits or together with the actions of microtubule 
motor proteins. Microtubules are also one of the major elements of neuronal 
cytoskeleton and they have roles in axonal transport. 
Acrylamide is and ,-unsaturated carbonyl compound which is highly water 
soluble. It has broad industrial application; e.g., polymer production, ore processing, 
mineral processing, cosmetic additives etc. Acrylamide is a toxicant which has 
genotoxic, carcinogenic, male reproductive toxic effects as well as neurotoxic 
effects. Acrylamide causes a central – peripheral distal axonopathy. The 
morphological hallmark of this axonopathy is considered to be axon degeneration, 
which begins as multifocal  paranodal swellings of preterminal distal fibers. The 
symptoms of acrylamide neurotoxicity are skeletal muscle weakness of the 
extremities, weight loss and uncoordinated gait.  
In this study, in vitro effects of acrylamide on microtubules were investigated using 
different methods. Firstly, tubulin proteins were purified from bovine brain after 
repetitive cycles of polymerization and depolymerization steps and ion-exchange 
chromatography. To show the effects of acrylamide on microtubules, sedimentation 
assay, fluorescence spectrometer, malachite green procedure and transmission 
electron microscopy techniques were used. During sedimentation assays, tubulin was 
exposed to acrylamide in different conditions, and in some experiments taxol-
stabilized microtubules were treated with acrylamide. Fluorescence spectrometer was 
used to show structural transition of microtubules in the presence of acrylamide 
through intrinsic fluorophore tryptophan residues in tubulin subunits. Pi amounts 
occuring during microtubule polymerization in the presence of acrylamide were 
measured by Malachite Green Procedure. In addition, to observe the structures that 
pelletted in the sedimentation assay and fluorescence spectrometer acylamaide-
treated taxol-stabilized microtubules were examined by Transmission Electron 
Microscopy.   
 
 1 
1. INTRODUCTION 
1.1. Cytoskeleton 
During evolution, a further level of organization of cells was provided by the 
cytoskeleton, which consists of a network of protein filaments extending throughout 
the cytoplasm of all eukaryotic cells. The cytoskeleton provides a structural 
framework for the cell, like serving as a scaffold that determines the cell shape and 
general organization of the cytoplasm. In addition to playing this structural  role, the 
cytoskeleton is responsible for cell movements. These include not only the 
movements of entire cells, but also the internal transport of organelles and other 
structures such as mitotic chromosomes  through the cytoplasm [1, 2].  
Cytoskeleton is a dynamic structure that is continually reorganized as cells move and 
change shape. Three types of protein filaments form the cytoskeleton: actin 
filaments, intermediate filaments and microtubules. However, these filaments are 
held together and linked to subcellular organelles and the plasma membrane by a 
variety of accessory proteins [2].  
1.1.1. Microtubules 
Microtubules are long protein polymers which are involved in the cell motility and 
determination of cell shape (Figure 1.1). Microtubules are responsible for various 
cell  movements like beating of cilia and flagella, the transport of membrane vesicles 
in the cytoplasm. These movements result from the polymerization and 
depolymerization of microtubules or the actions of microtubule motor proteins. 
However, some cell movements such as the alignment and separation of 
chromosomes during mitosis and meiosis involve both processes [2, 3]. 
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Figure 1.1.  General organization of microtubules in a typical cell. 
1.1.1.1. Microtubule Structures 
Microtubules are composed of a globular protein called “tubulin”. Tubulin is a dimer 
consisting of two 55 kDa polypeptides, α-tubulin and β-tubulin. These monomers are 
found in all eukaryotes and their sequences are highly conserved: 36-42 % identical 
and 63 % homologous. After polymerization of tubulin subunits, a cylindrical tube 
which is 24 nm in diameter occurs (Figure 1.2A). However, its lenght varies from a 
fraction of micrometer to hundreds of micrometers [1, 2].         
 
                
Figure 1. 2. A) Tubulin dimer and microtubule structure. B) A model of γ-TuRC. This complex is 
thought to nucleate microtubule assembly by presenting a row of of γ-tubulin subunits, which can 
directly bind αβ-tubulin subunits. 
In addition, a third type of tubulin  which is not a part of microtubules exists, γ-
tubulin. It is spesifically localized to the centrosome, where it plays a critical role in 
the initiation of microtubule assembly and it is the part of γ-TuRC (γ-tubulin Ring 
Complex) (Figure 1.2B) [2].                                  
The interactions holding α-tubulin and β-tubulin in a heterodimeric complex  are 
strong enough that a tubulin subunit rarely dissociates under normal conditions. 
A) B) 
 3 
Dimers dissociate into monemers with a Kd that varies between 0.06 and 0.32 μM, 
depending on nucleotide and magnesium concentration. Magnesium at the N-site  (or 
N-terminal of tubulin) controls the stability of the dimer, and its dissociation is 
followed by the  release of bound nucleotide and functional inactivation [4, 5].   
There are two GTP-binding sites on a tubulin dimer, one on α-tubulin and one on β-
tubulin (Figure 1.3). The GTP-binding site which is located on α-tubulin, binds GTP 
irreversibly and does not hydrolyze it. The site which is on β-tubulin, binds GTP 
reversibly and hydrolyzes it. This site is also called exchangeable site, because GDP 
can be replaced by GTP. Magnesium increases the affinity of the β subunit for GTP 
with respect to GDP, and in its presence the binding constants are 0.062 μM 
(compared to 71 μM in the absence of magnesium) and 0.18 μM, respectively. A 
nucleotide in oligomeric tubulin or in microtubules does not exchange with the 
solution, except for terminal subunits at the microtubule ends [2, 5, 6]. 
 
 
 
 
 
 
 
Figure 1.3. Structure of tubulin monomers and GTP binding sites on - and - tubulin. The 
anticancer drug taxol (black) is used to stabilize the microtubule structure.   
Head to tail arrays of tubulin dimers form protofilaments. Therefore, dimeric 
subunits repeat every 8 nm. 13 linear protofilaments assemble around a hollow core 
and form microtubules (Figure 1.4). Maintenance of the tubular form is provided by 
lateral and longitudinal interactions between tubulin subunits. In some cases, singlet 
microtubules contain more or fewer protofilaments; for example, certain 
microtubules in the neurons of nematode worms contain 11 or 15 protofilaments. 
However, there are doublet and triplet microtubules in specialized structures such as 
cilia and flagella (douplet microtubules) and centriols and basal bodies (triplet 
 4 
microtubules). Each of these contains one complete 13-protofilament microtubule 
and one or two additional tubules consisting of 10 protofilaments (Figure 1.5) [2, 3]. 
 
 
 
 
 
 
 
    
 
 
 
 
 
Figure 1.4. Microtubule structure. Free αβ-tubulin dimers associate longitudinally to form short 
protofilaments. These protofilaments are probably unstable and quickly associate laterally into more 
stable curved sheets. Eventually, a sheet wraps around into a microtubule with 13 protofilaments. The 
microtubule then grows by the addition of subunits to the ends of protofilaments composing the 
microtubule wall. 
                        
Figure 1.5. Arrangement of protofilaments in singlet, doublet and triplet microtubules. 
Microtubules are polar structures because of the head-to-tail arrangement of the α- 
and β-tubulin dimers in a protofilament. One end of a microtubule is ringed by α-
tubulin, whereas the other end is ringed by β-tubulin because of the same orientation 
of all protofilaments. These two different ends are named as a fast-growing plus end 
and a slow-growing minus end (Figure 1.6). This polary is an important 
consideration in determining the direction of movement along microtubules [7, 8]. 
 5 
                    
Figure 1.6. Microtubule polarity due to head to tail arrays of tubulin dimers. (+) end is ringed by -
tubulin and (-) end is ringed by -tubulin.  
There are two populations of microtubules: stable, long-live microtubules and 
unstable, short-live microtubules. Some cells, usually non-replicating cells, contain 
stable microtubule-based structures, for instance, the axoneme in the flagellum of 
sperm and the marginal band of microtubules in most red blood cells and platelets 
and also in nerve cells. Unstable microtubules are found when cell structures 
composed of microtubules need to assemble and disassemble quickly such as mitotic 
cells [3, 9].  
1.1.1.2. Microtubule Assembly and Disassembly 
In most cells, microtubules extend outward from a microtubule-organizing center 
(MTOC). In this kind of organization, mostly the minus ends are anchored in these 
centers and plus ends extend toward the cell mebrane so called radial localization. In 
animal cells, the MTOC is a centrosome, which is a pinwheel array of triplet 
microtubules and located adjacent to the nucleus near the center of interphase cells 
(Figure 1.7). Centriols are not present in plants and fungi and also in some epithelial 
cells and newly fertilized eggs from animals. In these cases, the associated proteins 
in an MTOC have the capacity to organize cytosolic microtubules. However,  in 
vitro experiments showed that necessary concentration of dimers to permit 
spontaneous formation of microtubules is lower in the presence of MTOCs relatively  
[10, 11, 12].  
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Figure 1.7. Orientation of cellular microtubules around MTOC in an interphase cell and a mitotic 
cell. 
MTOCs contain many proteins that are necessary for initiating the assembly of 
microtubules, and γ-tubulin is one of these. It has been shown that antibodies against 
γ-tubulin block microtubule assembly within the cells. Approximately 80 % of the γ-
tubulin in cells is part of a 25S complex, which has been isolated from extracts of 
frog oocytes and fly embryos. It is named as γ-tubulin ring complex (γ-TuRC) for its 
ringlike appearance in the electron microscope. In vitro experiments show that the γ-
TuRC can directly nucleate microtubule assembly at subcritical tubulin 
concentrations (Figure 1.2B) [13].  
The critical concentration (Cc) is the concentration of dimeric αβ-tubulin in 
equilibrium with microtubules. At dimer concentrations above the Cc, tubulin 
subunits polymerize into microtubules, while at concentrations below the Cc, 
microtubules depolymerize. However, the addition of fragments of flagellar or other 
microtubules to a solution of αβ-tubulin accelerates the initial polymerization rate by 
acting as nucleation sites [2, 14].  
At αβ-tubulin concentrations higher than the Cc for polymerization, dimers add to 
both ends of a growing microtubule. Yet, the addition of tubulin subunits occurs 
preferentially at one end. This difference between the two ends of a growing 
microtubule is demonstrated by examining electron micrographs of microtubules that 
have assembled from the ends of nucleating flagellar fragments in vitro. The electron 
micrographs show a tuft of microtubules sprouting from both ends of the fragment, 
but one tuft is much longer than the other. The preferred assembly end is designated 
as the (+) end, and the end that assembles more slowly is the (-) end. When the 
tubulin concentration is diluted below the  Cc, the microtubules disassemble twice as 
rapidly at the (+) end as at the (-) end. Thus both assembly and disassembly occur 
preferentially at the (+) end [2, 14].  
A) B) 
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In the electron microscope, growing microtubules appear to have relatively smooth 
ends, although some protofilaments are longer than others, indicating that they 
elongate unevenly. The appearance of microtubules undergoing shortening is quite 
different, suggesting that the mechanism of disassembly differs from that of 
assembly. Under shortening conditions, the microtubule ends are splayed, as if the 
lateral interactions between protofilaments have been broken. Once frayed apart and 
freed from lateral stabilizing interactions, the protofilaments might depolymerize by 
endwise dissociation of tubulin subunits  (Figure 1.8.) [2]. 
             
Figure 1. 8. Cryoelectron microscopy of assembling (A) and disassembling (B) microtubules.  
Once microtubules have assembled, their stability is temperature-dependent. For 
instance, if microtubules are cooled down to 4° C, they depolymerize into stable αβ-
tubulin dimers. When warmed up to 37° C in the presence of GTP, the tubulin 
dimers polymerize into microtubules (Figure 1.9) [7]. 
                                    
Figure 1. 9. Temperature affects whether microtubules (MTs) assemble or disassemble. 
 
  A)   B) 
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1.1.1.3. Dynamic Instability of Microtubules 
Under favorable in vitro conditions, microtubules exhibit the ability to treadmill, in 
which subunits add to one end  and dissociate from the opposite end (Figure 1.10). 
Furthermore, a single microtubule can oscillate between growth and shortening 
phases. In all cases, the rate of microtubule growth is much slower than the rate of 
shortening [15].  
 
 
 
Figure 1. 10. Tubulin subunits add to one end and dissociate from the opposit end. 
Two conditions influence the stability of microtubules. First, the oscillations 
between growth and shrinkage in vitro occur at tubulin concentrations near Cc. At 
tubulin concentrations above the  Cc, the entire population of microtubules grows, 
and at concentrations below the Cc, all microtubules shrink. At concentrations near 
the Cc, however, some microtubules grow, while others shrink [10, 15]  .  
The second condition affecting microtubule stability is whether GTP or GDP 
occupies the exchangeable nucleotide-binding site on β-tubulin at the (+) end of a 
microtubule. A microtubule becomes unstable and depolymerizes rapidly if the (+) 
end becomes capped with subunits containing GDP-β-tubulin rather than GTP-β-
tubulin. This situation can arise when a microtubule shrinks rapidly, exposing GDP-
β-tubulin in the walls of the microtubule, or when a microtubule grows so slowly 
that hydrolysis of GTP bound to β-tubulin converts it to GDP before additional 
subunits can be added to the (+) end of the microtubule [5, 16].  
Before a shortening microtubule vanishes, it can be rescued and start to grow if 
tubulin subunits with bound GTP add to the (+) end before the bound GTP 
hydrolyzes. Thus, the one parameter that determines the stability of a microtubule is 
the rate at which GTP-tubulin subunits are added to the (+) end. Possible factors that 
switch a microtubule between growth and shrinkage have been identified. One is a 
microtubule-severing protein, katanin, which may generate nuclei at centrosomes. 
Another factor is Op 18, which increases the frequency of catastrophe, possibly by 
binding tubulin dimers [16]. 
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1.1.1.4. Microtubule Motor proteins  
Cells can accomplish a remarkable number of animated tasks due to the actions of 
proteins that convert chemical energy into force and motion (Figure 1.11). The 
eukaryotic motors hydrolyse nucleotides and harness the derived energy to move 
unidirectionally along cytoskeletal polymers.  Motor proteins are mostly categorized 
according to the type of cytoskeletal polymer with which they interact. Myosins, a 
large protein family, move along actin filaments. Motors that utilize intermediate 
filaments as tracks have not been described. On the other hand, microtubules interact 
with two types of force-generating motors: dyneins and kinesins.[17, 18].   
                     
Figure 1. 11. General model of kinesin- and dynein- mediated transport in a typical cell.  
Related motor proteins are categorized as superfamilies such as myosins, kinesins 
and dyneins. The membership sign for belonging to a motor superfamily is amino 
acid identity within the motor domain, a region of the polypeptide that is responsible 
for force generation. The non-motor regions or tail domains can differ considerably 
in size, structure and amino acid sequences. These diverse regions confer unique 
self-assembly properties as well as binding interactions [19,20]. 
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Figure 1. 12. Vesicle or organelle transport in cytoplasm by kinesin and dynein on microtubule track. 
Kinesin 
Kinesin moves toward the (+) end of the microtubules so it is called (+) end-directed 
microtubule motor protein.  It is a dimer of two heavy chains, each complexed to a 
light chain, with a total molecular weight of 380 kDa. The molecule is organized into 
three domains, a pair of large globular head domain connected by a long central stalk 
to a pair of small globular tail domain, which associates with the light chains (Figure 
1.12) [20]. 
A 340 amino acid conserved sequence in the heavy chain, part of the globular head 
domains, possesses sequences for microtubule binding and ATP hydrolysis. The 
remainder of the heavy chains associate together as a α-helical coiled-coil to form a 
stalk. A natural disruption in the typical heptad repeat of the coiled-coil results in a 
kink in this filamentous portion, presumably endowing flexibility between the 
globular heads and the filamentous tails. Light chains are associated with the amino 
terminal ends of the heavy chain forming the tail. Each domain carries out a 
particular function: the head domain, which binds microtubules and ATP, is 
responsible for the motor activity of kinesin, and tail domain is responsible for 
binding to membrane vesicles. In light of the transport function of kinesin, a bound 
membrane vesicle is often referred to as kinesin’s cargo [20, 21]. 
The ATP-dependent reversible binding of kinesin to microtubules and 
conformational change between the head and the rest of the molecule permits 
locomotion of kinesin along the microtubule [20, 21]. 
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To date, more than 12 different family members have been identified. Each member 
transports a specific cargo. All kinesins contain the kinesin motor domain, but differ 
in their tail domains and several other properties. In most kinesins, the motor domain 
is at the N-terminus (N-type), but in some, the motor domain is central (M-type) or 
at the C-terminus (C-type). Both N- and M-type kinesins are (+) end-directed 
motors, whereas C-type kinesins are (-) end-directed motors. In addition, some 
kinesins are monomeric; however, most are dimeric. These two types of kinesins, 
differing in quaternary structure, may move along a microtubule by different 
mechanisms [22]. 
Kinesins can also be divided into two broad functional groups, cytosolic and spindle 
kinesins, based on the nature of the cargoes that they transport. The functional 
differences between kinesins may be related to their unique tail domains. Cytosolic 
kinesins are involved in vesicle and organelle transport; they include the classic 
axonal kinesin, implicated in transport of lysosomes and other membranous 
organelles. However, some cytosolic kinesins are responsible for transport of one 
specific cargo. For example, KIF1B transports mitochondria, and its relative KIF1A 
transports synaptic vesicles to the nerve terminal. In contrast, spindle kinesins 
participate in spindle assembly and chromosome segregation during cell division. 
This group comprises numerous proteins, including the kinetochore-associated 
protein CENP-E; the spindle pole protein BimC; and a (-) end-directed motor protein 
called ncd [22]. 
Dynein 
Dynein is a (-) end-directed motor protein. Dyneins are exceptionally large, 
multimeric proteins, with molecular weights exceeding 1,000 kDa. They are 
composed of two or three heavy chains (MW 470 -540 kDa) complexed with a 
poorly determined number of intermediate and light chains (Figure 1.12). The 
dyneins are divided into two functional classes: cytosolic dynein, which is involved 
in the movement of vesicles and chromosomes, and axonemal dynein, which is 
responsible for the beating of cilia and flagella [20].  
Like kinesin, cytosolic dynein is a two-headed molecule, with two identical or nearly 
identical heavy chains forming the head domains. However, unlike kinesin, dynein 
cannot mediate transport by itself. Rather, dynein-related motility requires a large 
complex of microtubule-binding proteins that link vesicles and chromosomes to 
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microtubules but by themselves do not exert force to cause movement. The best-
characterized complex is dynactin, a heterocomplex of at least eight subunits, 
including a 150 kDa protein called Glued, the actin-capping protein Arp1, and 
dynamatin [23]. 
1.1.1.5. Microtubule Associated Proteins (MAPs) 
Highly enriched tubulin preparations obtained after several assembly-disassembly 
cycles still contain small amounts of other proteins, which maintain their quantitative 
ratio to α- and β-tubulin through successive cycles. Co-purification of these proteins 
with tubulin suggested that they are not nonspecific contaminants but rather 
molecules that interact specifically with microtubules [2].  
One major family of MAPs, called assembly MAPs, is responsible for cross-linking 
microtubules in the cytosol. These MAPs are organized into two domains: a basic 
microtubule-binding domain and an acidic projection domain. In the electron 
microscope, the projection domain appears as a filamentous arm that extends from 
the wall of the microtubule. This arm can bind to membranes, intermediate 
filaments, or other microtubules and its lenght controls how far apart microtubules 
are spaced [24].  
Based on sequence analysis, assembly MAPs can be grouped into two types. Type I 
MAPs, MAP1A and MAP1B, contain several repeats of the amino acid sequences 
Lys-Lys-Glu-X, which is implicated as a binding site for negatively charged tubulin. 
This sequence is postulated to neutralize the charge repulsion between tubulin 
subunits within a microtubule, thereby stabilizing the polymer. MAP1A and MAP1B 
are large, filamentous molecules found in axons and dendrites of neurons and also in 
non-neuronal cells. Each of these proteins is derived from a single precursor 
polypeptide, which is proteolytically processed in a cell to generate one light chain 
and one heavy chain [24, 25].  
Type II MAPs include MAP2, MAP4 and Tau. These proteins are characterized by 
the presence of four repeats of an 18-residue sequence in the microtubule-binding 
domain. MAP2 is found only in dendrites, where it forms fibrous cross-bridges 
between microtubules and also links microtubules to intermediate filaments. MAP4, 
the most ubiquitous of all MAPs, is found in neuronal and non-neuronal cells. It is 
thought to regulate microtubule stability during mitosis. Tau, which is much smaller 
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than most other MAPs, is present only in the axons. This protein exists in four or 
five forms derived from alternative splicing of tau mRNA. The ability of Tau to 
cross-link microtubules into thick bundles may contribute to the stability of axonal 
microtubules [24, 25]. 
When MAPs coat the outer wall of a microtubule, tubulin subunits are unable to 
dissociate from the ends of a microtubule. Although the rate of microtubule 
disassembly is generally dampened by bound MAPs, the assembly of microtubules is 
affected to varying degrees: some MAPs, like MAP4 and Tau, stabilize 
microtubules, whereas other MAPs do not [25]. 
1.2. Neuronal Cytoskeleton 
Neurons have two distinct types of processes extending from a cell body; axons and 
dendrites (Figure 1.13A). The neuronal cytoskeleton is comprised of two major 
elements: neurofilaments and microtubules. Both axons and dendrites are supported 
by stable microtubules together with the neurofilaments (Figure 1.13B) [26].  
Figure 1. 13. A) A typical neuron with a long axon and dendrites. B) Microtubules and intermediate 
filaments are oriented longitudinally in axon and they are cross-linked by various proteins. 
In axons, neurofilaments and microtubules are aligned paralel to the longitudinal 
axis of the axon with the neurofilaments forming cross-bridged complexes with 
themselves as well as neurotubules [26]. However, the microtubules in axons and 
dendrites are organized differently and associate with distinct MAPs. In axons, the 
microtubules are all oriented with their plus ends away from the cell body, similar to 
the general organization of microtubules in other cell types. The minus ends of most 
  A) B) 
 14 
of the microtubules in axons, however are not anchored in the centrosome. Instead, 
both plus and minus ends of these microtubules terminate in cytoplasm of the axon. 
In dendrites, the microtubules are oriented in both directions; some plus ends point 
toward the cell body and some point toward the cell periphery (Figure 1.14). These 
distinct microtubule arrangements are paralleled by differences in MAPs: Axons 
contain tau proteins, but no MAP-2, whereas dendrites contain MAP-2, but no Tau 
proteins [27, 28, 29].     
 
Figure 1. 14. In nerve cells, the (-) ends of all axonal microtubules are oriented toward the base of the 
axon, but dendritic microtubules have mixed polarities. 
1.2.1. Axonal Transport 
The axon is dependent upon the soma for production of vital macromolecules. In 
some instances, the volume of the axon may exceed that of the cell body by 1000-
fold, placing a massive metabolic demands on the cell body. In addition, an intra-
cellular transport system is required to function efficiently for delivery of de novo 
synthesized macromolecules to the various axonal and dendritic domains [26].    
However, substances which consist mainly of old membrane from the synaptic 
terminals, are destined to be degraded in lysosomes in the cell body. Therefore, 
axonal transport can be classified as anterograde and retrograde axonal transport 
(Figure 1.15) [30]. 
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Figure 1. 15. Anterograde and retrograde transport in a typical neuron.  
1.2.1.1. Anterograde Axonal Transport 
Nerve impulses are transmitted from a neuron by release of neurotransmitters from 
the terminal of the axon, the very long process that extends from the cell body. The 
neuron must constantly supply new materials to the terminal to replenish those lost 
by exocytosis at the synapse. Ribosomes are mainly present in the cell body and the 
dendrites of nerve cells. Therefore, proteins and membranes must be synthesized in 
the cell body and then transported down the axon, which can be up to several meters 
in length, to the synaptic regions [30]. 
The anterograde axonal transport proceeds from the cell body to the synaptic 
junctions and is associated with axonal growth and the renewal of synaptic vesicles. 
It is also divisible into fast and slow components. In addition to different rates of 
movement, different materials are conveyed in the two components. The slow 
component is defined as movement of the cytoskeleton at rates of 0.5-5 mm per day 
[24]. Fast anterograde axonal transport represents a spectrum of rates ranging from 
200 to 400 mm per day. Conveyed in this system is a variety of proteins, 
glycoproteins, and glycolipids destinated for the axolemma, mitochondria and 
synaptic vesicles including neurotransmitters and the enzymes associated with 
neurotransmitter generation and/or regeneration. These components are moved along 
microtubules by the motor protein kinesin. The anterograde direction of kinesin 
transport is the combined result of polarized microtubules, the dedicated movement 
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of kinesin toward the faster growing plus end and the cellular distribution of 
microtubules with their plus end distally [30, 31]. 
1.2.1.2. Retrograde Axonal Transport 
Retrograde axonal transport operates at approximately half the rate of fast 
anterograde transport. The mechanism is similar to fast anterograde transport; 
membrane bound organelles (MBOs) are conveyed along microtubules with a motor 
protein [30].  
One difference between anterograde and retrograde transport is that the vesicles 
conveyed by retrograde transport are larger than those conveyed in the fast transport 
system. In addition to mitochondria, multivesicular or lysosomal types of vesicles 
are often observed. A second difference is the use of the motor protein, cytoplasmic 
dynein. The locomotion is directed toward the minus or slow-growing end. 
Microtubule orientation dictates dynein-directed movement in the retrograde 
direction [26]. 
1.3. Acrylamide 
1.3.1. Structure 
Acrylamide is an ,-unsaturated carbonyl compound. It is a highly water-soluble, 
solid substance at room temperature with a molecular weight of  71.08. Monomeric 
acrylamide readly participates in radical-initiated polymerization reactions [32].   
 
 
Figure 1. 16. Chemical structure of acrylamide monomer. 
1.3.2. Chemical and Physical Properties 
Acrylamide is a colorless to white, odorless crystalline solid. When further purified 
with benzene, it precipitates as a leaf of flake-like crystal. Its solubility in various 
solvents at 30°C is as fallows: water 215.5 g/100 ml, methanol 155 g/100 ml, ethanol 
86.2 g/100 ml, acetone 63.1 g/100 ml, ethyl acetate 12.6 g/100 ml, chloroform 2.66 
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g/100 ml, benzene 0.346 g/100 ml and heptane 0.0068 g/100 ml. Acrylamide has a 
density of 1.122 g/cm3 at 30°C, a melting point of 84.5°C and boiling point of 125°C 
at 25 torr. It has a vapor pressure of 0.007 torr at 25°C and relative vapor density 
(air=1) of 2.45. Acrylamide (solid) is stable at room temperature, but polymerizes on 
melting or exposure to ultraviolet radion [33]. 
1.3.3. Production 
Acrylamide was first produced in 1893 by Moureu in Germany. In 1952, Hercules 
started making research quantities and by 1954 began commercial production [33]. 
Acrylamide is formed from the hydration of acrylonitrile with sulfuric acid 
monohydrate at 90-100°C. From the resulting sulfate solution acrylamide is 
extracted by neutralization with ammonia and subsequent cooling to isolate the 
crystalline monomer. The reaction of acrylonitrile with sulfuric acid and water is 
highly exothermic, and produces by-products of polyacrylamide and acrylic acid. 
The addition of copper salts can suppress side reactions leading to these by-products. 
In 1971, a direct catalytic conversion of acrylonitrile to acrylamide was developed, 
thereby eliminating by-products. By this method, an aqueous solution of acrylonitrile 
is passed over a fixed bed of copper or copper-metal admixtures at 25-200°C. 
Unreacted aqueous acrylonitrile can be recycled by subsequent oxidation reaction. 
[33, 34]. 
Acrylamide monomer is used primarily for the production of polyacrylamides with 
widely different physical and chemical properties. These high-molecular-weight 
polymers can be modified to have non-ionic, anionic or cationic properties for 
specific uses. Polymerization (homopolymerization and copolymerization) is 
brought about through a free-radical mechanism in aqueous solution. The solubility 
and polyelectrolyte characteristics of these polymers are imparted by residual 
carboxyl groups or hydrolysed amide groups. Water-soluble cationic polymers can 
be produced by copolymerization with unsaturated quaternary  ammonium 
compounds such as diallyldimethyl ammonium chloride and vinylbenzyltrimethyl 
ammonium chloride. Anionic polyacrylamides are formed by copolymerization with 
carboxylic or sulfonic acids [32, 33]. 
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1.3.4. Usage 
Acrylamide polymers have broad industrial application; e.g., polymer production, 
ore processing, mineral processing, concrete processing, cosmetic additives, soil and 
sand treatment, coating applications, oil production process, dye and fiber synthesis, 
water purification, soil stabilization, pulp and paper, fabric, textile industries and 
also are used in molecular biology laboratories as laboratory electrophoresis gels 
[32, 35, 36, 37, 38].  
1.3.5. Disposal and Environmental Fate 
Acrylamide may be disposed of by polymerization in landfills, dissolved in large 
quantities of water, hydrolysed with hot sodium or calcium hydroxide or incinerated, 
provided that there is provision for scrubbing of nitrogen oxide from flue gases [33].  
Acrylamide and its monomeric analogues are readily leachable in soil and may travel 
great distances in the ground-water of deep rock aquifers. Bioconcentration and 
accumulation of acrylamide in food chain organisms are unlikely because of its 
higher solublilty in water when compared to n-octanol, an in vitro indicator of fat 
solubility and membrane transversibility. Thus, acrylamide will not accumulate in 
fatty tissues. Furthermore, a wide variety of microbes possess the ability to degrade 
acrylamide under light or dark, anaerobic or aerobic conditions [33].  
Acrylamide is not a normal substrate used by microorganisms and they require a 
period of time to adjust. Thus, a lag  period of several days, weeks or months may  
occur before any significant degradation is observed. In laboratory experiments, 
acrylamide was not absorbed by sewage sludge, natural sediments, clays, peat, or 
synthetic resins over the pH range of 4-10. Thus, acrylamide in contaminated water 
cannot be removed by water treatment [32]. 
1.3.6. Exposure and Metabolism  
Humans are exposed to acrylamide during its manufacture, in grouting operations, 
by leaking of acrylamide from polyacrylamide used in the purification of drinking 
water, and in laboratories using acrylamide for the preparation of chromatographic 
gels. In addition, humans consuming carbohydrate-rich foods processed at high 
temperatures are exposed to acrylamide [33, 39].   
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Acrylamide is absorbed by all routes of exposure, such as oral, intravenous, 
intraperitoneal, subcutaneous, dermal or inhalation. Once absorbed, acrylamide is 
rapidly distributed throughout the body, metabolized and excreted. In 
autoradiographic studies of mice, Marlowe et al. (1986) found that radioactivity 
from acrylamide is evenly distributed among tissues, although 9 days after treatment 
the label was found to have accumulated in the reproductive tract. The tissues with 
the highest amounts of radioactivity were muscle, skin, blood and liver. By contrast, 
the lowest concentrations were found in nervous tissues [32, 40]. 
Following uptake, acrylamide may be conjugated with glutathion to take place in the 
bile and the liver. It is then excreted in the urine as the mercapturic acid N-acetyl-S-
(2-carbamoylethyl) cysteine, or it may be oxidized to glycidamide. Acrylamide has 
also been reported to be excreted unchanged in the urine. The conjugation of 
acrylamide to glutathion is mediated by glutathion transferase. Also it is observed 
that the metabolic conversion of acrylamide to glycidamide is mediated by the 
cytochrome P450 system. The metabolite glycidamide either reacts with glutathion, or 
is excreted intact or as the hydrolysis product of glyceramide. However glyceramide 
may undergo further oxidation to substances with a labile 1-2 carbon bond, resulting 
in the release of carbon dioxide [32]. 
1.3.7. Acrylamide formation in foods 
Although foods have been cooked at the same way for a significant amount of time, 
it was not known that the chemical would turn up in food until 2002. When Swedish 
researchers were conducting studies on the health risks to workers who had been 
exposed to acrylamide while on the job, they discovered the connection to food. The 
control group for the study, people who had not been exposed to acrylamide at work, 
had high levels of acylamide in their bodies, leading researchers to look for other 
sources of exposure such as diet [41].  
The researchers found, and the U.S. Food and Drug Administration (FDA), the U.K. 
Food Standards Agency and many other countries confirmed, significant levels of 
acrylamide in a wide range of foods as a result of baking or frying, and it is likely 
that the chemical is also produced by grilling and roasting food. Mottram and 
colleages reported that acrylamide is formed by Maillard reaction between 
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asparagine and glucose and that this reaction might happen during high-temperature 
(above 120°C) cooking and food processing (Figure 1.17) [42, 43, 44]. 
 
 
 
 
 
 
 
 
 
Figure 1. 17. Diagram of acrylamide formation by Maillard reaction between glucose and asparagine.  
Interest in human exposure to acrylamide has recently regained notoriety due to its 
formation from asparagine in carbohydrate-rich foods such as French fries and patato 
chips, when cooked at high temperatures. Raw or even boiled potatoes test negative 
for the chemical. Acrylamide is also reported to be present in biscuits crackers, toast, 
soft bread, breakfast cereals and coffee powder. While the levels of exposure from 
consumption of these food sources may be carcinogenic, they appear well below 
what is necessary to cause neurotoxicity. Nevertheless, repeated exposures to 
acrylamide produce in both humans and experimental animals a distal axonopathy 
[42, 45, 46, 47, 48]. 
1.3.8. Toxicity 
Acrylamide monomer has been known as a toxicant for more than for decades. It has 
been identified as genotoxic, carcinogenic, and a male reproductive toxicant, as well 
as a neurotoxicant [49, 50, 51]. 
1.3.8.1. Genotoxicity and carcinogenecity 
EU Risk Assessment Report indicates that acrylamide is carcinogenic in animals 
producing increased incidences in a number of bening and malignant tumours in a 
variety of organs. The tumour types observed show a possible relationship with 
disturbed endocrine function and raise the possibility of a hormonal mechanism. 
There is also a suggestion of acrylamide-induced tumours in brain and spinal cord. 
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International Agency for Research on Cancer (IARC) reports that acrylamide 
induces gene mutation, structural chromosomal aberrations, sister chromatid 
exchange and mitotic disturbances in mamalian cells in vitro in the presence or 
absence of exogenous metabolic systems [49, 50].  
Acrylamide and its metabolite glycidamide form covalent adducts with DNA in mice 
and rats. It induces structural chromosomal aberrations in vivo in both somatic and 
germ-line cells. Treatment with acrylamide in vivo also caused somatic mutation in 
the spot test, heritable translocation and specific locus mutations in mice, and 
dominant lethal mutations in both mice and rats in several studies. Acrylamide 
induces unscheduled DNA synthesis in rat spermatocytes in vivo but apparently not 
in rat hepatocytes. It was also reported to induce transformation in cultured 
mammalian cells and sex-linked recessive lethal and somatic mutations in 
Drosophila [52, 53]. 
1.3.8.3. Male Reproductive Toxicity 
There are no human data available on reproductive toxicity of acrylamide. However, 
over the past 10 years, there have been a large number of studies investigating the 
effects of acrylamide on rodent reproductive performance to conclude that 
acrylamide is a reproductive toxicant in male rats and mice bred to untreated 
females. In addition, acrylamide does not affect female reproduction in rats and 
mice. These rodent data are assumed relevant to humans [54]. 
Male reproductive toxicity was manifested as impaired delivery of sperm to the 
female genital tract and reduction of live litter size due to increased post 
implantation loss. However, alterations in sperm function and motility, low hormone 
levels and testicular atrophy have been observed at high doses when the animals are 
already being intoxicated by the peripferal or central neurotoxicity, and/or by the 
clastogenic effects which appear to result from the interaction of acrylamide (or its 
metabolite glycidamide) with protamines during spermatogenesis in the seminiferous 
tubules or testes. In addition, there are sufficient data to conclude that acrylamide 
induces transmissible genetic damage in male germ cells of mice in the form of 
reciprocal translocations and gene mutations. Such effects can lead to genetic 
disorders and infertility in subsequent generations [51, 54]. 
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Subsequently, the mechanisms of action of acrylamide reproductive toxicity appear 
to be: 
1. Acrylamide and/or glycidamide binding to spermatid protamines results in 
dominant lethality due to  induced clastogenesis and effects on sperm morphology. 
2. Acrylamide interference with molecular transport between the neuron cell body 
and axon resulting in distal axonapathy, and therefore, hindlimb weakness, perhaps 
also anesthesia to the penis, resulting in effects on mounting and intromission and 
effects on sperm motility due to interference with flagellar function [54]. 
1.4. Acrylamide neurotoxicity 
The burgeoning commercial use of acrylamide during the 1950s was accompanied 
by growing concern over potential toxicity. There have been case reports in 
monomer and polymer manufacturing sectors of worker peripheral neurotoxicity. 
Early studies indicated that exposure of humans and laboratory animals to 
acrylamide produced skeletal muscle weakness and ataxia. Subsequent researches 
suggested this behavioral neurotoxicity was related to nerve damage classified as a 
central-peripheral distal axonopathy [55, 56].  
The morphological hallmark of this axonopathy is considered to be axon 
degeneration, which begins as multifocal  paranodal swellings of preterminal distal 
fibers. Axonal swellings contain an abundance of neurofilaments, tubulovesicular 
profiles and degenerating mitochondria [57].  
More recent studies have suggested axonal atrophy also is a morphologic component 
of acrylamide peripheral neuropathy. Axonal atrophy and segmental demyelination 
have been observed frequently and are considered as secondary phenomena. Because 
of the retrograde progression of degeneration, this type of toxic nerve injury was 
termed a “dying back” neuropathy by Cavanagh at 1964. Clinically, toxic 
axonopathies are associated with skeletal muscle weakness of the extremities, weight 
loss and uncoordinated gait (ataxia) [57, 58]. 
The acrylamide has been placed in a group of substances showing an 
organophosphorus pattern of degeneration. It is one of the recognized prototypical 
agents among the numerous compounds that produce this type of neuropathy and a 
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majority of studies investigating mechanisms of distal axonopathies have focused on 
this chemical [31, 59]. 
Acrylamide produces a retrograde axonal degeneration in nevre fibers of Peripheral 
Nervous System and Central Nervous System. In intoxicated animals, acrylamide 
was reported to impair either the slow phase or the rapid phase of the axonal 
transport of proteins in spinal roots and in long peripheral nerves. Short axons have 
been previously found to be less affected than long axons in acrylamide intoxicated 
animals [60]. 
1.4.1. Possible Mechanisms of Neurotoxicity 
Although acrylamide neurotoxicity has been known for four decades, the exact 
mechanism of toxicity is still unknown. Based upon the time course of recovery of 
transport, the target must be one that is rapidly replenished within the axon. 
Identification of the molecular site of action is complicated by simultaneous 
compromise of both anterograde and retrograde transport systems by agents regarded 
as specific for one. Four targets have received the most attention; enzymes of 
intermediary metabolism, neurofilaments, motor proteins and microtubules.  
1-In 1979, Spencer et al. first proposed the energy hypothesis as a mechanism of 
acrylamide neurotoxicity. Covalent binding of acrylamide to glycolytic enzymes 
such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which had been 
shown vital to axonal transport, was suggested to cause reduced axonal transport by 
depletion of the required levels of ATP. In support, numerous enzymes were 
identified as inhibited by acrylamide such as enolase and phosphofructokinase [61]. 
In addition, LoPachin et al. focused their studies on effects of acrylamide on Na+/K+-
ATPase activity. They proposed reduced Na+/K+-ATPase activity as an initiating 
event in ion disruption associated with swollen and, possibly, atrophied regions of 
distal axons. They measured rubidium (Rb+) transport as an index of enzyme 
function. X-ray microanalysis was used to quantify elemental Rb uptake and 
accumulation in internodal myelinated axons, mitochondria, Shwann cells and 
myelin of rat tibial nerve cryosections. Their results demonstrated impairment of Rb 
uptake in tibial axons [34]. 
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2-The neurofilament (NF) hypothesis suggests that the neurotoxicant covalently 
binds to and modifies the NF subunits. In the case of acrylamide, the primary 
reactive group would be protein sulfhydryls. The modified NF either inappropriately 
interacts with other cytoskeletal elements and/or accumulates within the axon. The 
improper function and/or distribution of NFs are proposed to compromise fast 
transport, reducing delivery of vital macromolecules to the distal axon [61]. 
In 1985, Howland et al. assayed the activity of protein kinase in neurofilament 
preparations from spinal cords of rats treated with acrylamide. They observed 
significantly increased total phosphorylation of neurofilament preparations. 
According to these results they suggested that one possible cause of abnormally 
arranged neurofilaments in acrylamide induced neuropathy was related to an altered 
phosphorylation of these cytoskeletal elements [62]. 
3-The potential effect of acrylamide on the motor protein kinesin is consistent with 
the characteristics of reduced fast anterograde transport by this toxicant. Kinesin is 
one the candidates due to the dependence of kinesin function on sulfhydryl groups 
and the binding of acrylamide to protein sulfhydryls. 
Sickles et al. evaluated kinesin as a molecular site of action using an in vitro 
microtubule motility assay. Their results demonstrated that pretreatment of kinesin 
with acrylamide adversly affected both the number and rate of microtubule moving 
in an in vitro motility. However, they observed decreased numbers of microtubules 
gliding over the kinesin-adsorbed coverslip and frequent dissociation of gliding 
microtubules. They suggested that this effect resulted from a direct and irreversible 
binding of acrylamide to kinesin [63]. 
4-The dependence of fast axonal transport upon the axonal microtubule railway 
system and the compromise of transport by microtubules poisons suggested this 
cytoskeletal element as a potential site of action. Radio-labeled acrylamide has been 
showed to bind tubulin and acrylamide reduced the binding of radio-labeled 
colchicine [34]. 
Some studies resulted in no change in microtubule assembly/disassembly following 
acrylamide. However, in 1997, Abou-Donia et al. reported an increased rate of 
polymerization and a decrease in time to Vmax following acrylamide treatment [64]. 
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In addition, Sickles et al. observed that microtubule motility was adversly affected 
when tubulin was preincubated with acrylamide due to doubled microtubule 
detachment rate during in vitro microtubule motility assay [63]. 
In this thesis study, we investigated whether microtubules are the site of action for 
neurotoxic effects of acrylamide. In previous studies it has been shown that axon 
degeneration, which begins as multifocal paranodal swellings of preterminal distal 
fibers is the morphological hallmark of axonapathy. Axonal swellings contain an 
abundance of neurofilaments, tubulovesicular profiles and degenerating 
mitochondria. Since microtubules are the major elements of axonal transport, they 
are one of the candidates as the responsible ones for impaired axonal transport. 
However, time recovery of neurotoxicity is one of the reasons to show microtubules 
as targets of acrylamide neuropathy. 
We used microtubule sedimentation assay, fluorescence spectrometer and malachite 
green procedure to evaluate the effects of acrylamide on polymerization kinetics of 
microtubules. In addition, transmission electron microscopy has been used to 
examine the structures that pelletted in the sedimantation assay and fluorescence 
spectrometer. 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Buffers for Tubulin Purification 
2.1.1.1. 5x PM Buffer  
500 mM Pipes (Roche), 10 mM EGTA (Sigma) and 5 mM Mg SO4.7H2O (Riedel-de 
Haen) were dissolved in de-ionized water up to 1 lt and pH was adjusted to 6.9 with 
NaOH. The solution was stored at 4C    
2.1.1.2. 1x PM Buffer  
5x PM buffer was diluted with de-ionized water 5 times and pH was adjusted to 6.9. 
It was stored at 4C . 
2.1.1.3. PM-4M Buffer  
4 M glycerol (Carlo Erba) was dissolved in 1 lt 1x PM buffer and stored at 4C.                       
2.1.1.4. PM-8M Buffer  
8 M glycerol (Carlo Erba) was dissolved in 1 lt 1xPM buffer and stored at 4C.                       
2.1.1.5. PMSF Solution 
100 mM PMSF (Sigma) was dissolved in 10 ml isopropanol (Merk) and stored at 
room temperature. 
2.1.2. Buffers for Ion-Exchange Column Purification 
2.1.2. Ion-Exchange Column Preparation 
2.1.2.1. NaOH Solution 
0.5 M NaOH (Riedel-de Haen) was dissolved in de-ionized water up to 1.5 lt and 
stored at 4C.  
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2.1.2.2. HCl Solution  
0.5 M HCl (37 %) (Merk) was dissolved in de-ionized water up to 1.5 lt and stored at 
4C. 
2.1.2.3. 1x PM Buffer containing GTP and DTT 
0.1 mM GTP (Sigma) and 2 mM DDT (Sigma) were dissolved in 1 lt 1xPM buffer 
and stored at 4C. 
2.1.3. Solutions for Determination of Protein Concentration 
2.1.3.1. Bradford Reagent 
Bradford reagent (Sigma) was used as purchased and stored at 4°C. 
2.1.3.2. Bovine Serum Albumine (BSA) Stock Solution 
14.5 g BSA (Sigma) was dissolved in 10 ml de-ionized water and stored -20°C. 
2.1.4. Buffers for Reactions 
2.1.4.1. AB Buffer  
20 mM Pipes (Roche), 1 mM MgCl2 (Riedel-de Haen) and 1 mM EGTA (Sigma) 
were dissolved in 1 lt de-ionized water and pH was adjusted 6.9. The solution was 
stored at 4C      
2.1.5. Solutions for SDS-PAGE (Sodium Dodecyl Sulfate – Polyacrylamide Gel 
Electrophoresis) 
2.1.5.1. Acrylamide Monomer Solution (30% T/ 2.7% Cbis)  
58.4 g acrylamide (Sigma) and 1.6 g bis-acrylamide (Sigma) were dissolved in de-
ionized water up to 200 ml. Solution was stored in the dark and at 4C. 
2.1.5.2. 4x Running (Separating) Gel Buffer (1.5 M Tris-Cl) 
36.3 g tris (Merk) was dissolved in de-ionized water up to 200 ml. pH was adjusted 
to 8.8 with HCl. Solution was stored at 4C. 
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2.1.5.3. 4x Stacking Gel Buffer (0.5 M Tris-Cl) 
3 g tris (Merk) was dissolved in 50 ml de-ionized water and pH was adjusted to 6.8. 
Solution was stored at 4C. 
2.1.5.4. 10% Sodium Dodecyl Sulfate (SDS) 
10 g SDS (99 %) (Sigma) was dissolved in 100 ml  de-ionized water  and solution 
was stored at room temperature.                      
2.1.5.5. 10% Ammonium Persulfate (APS) 
0.1 g APS (Sigma) was dissolved in 1 ml  de-ionized water. Solution was stored at 
4C, had a two week life. 
2.1.5.6. TEMED (N, N, N’, N’ – Tetramethylethylene diamine) 
TEMED (Farmitalia Carlo Erba S.p.A.) was used as purchased and stored at 4C. 
2.1.5.7. 2xSample Buffer  
2.5 ml 4X Stacking Gel Buffer (0.125 M Tris-HCl, pH 6.8), 4 ml 10% SDS solution 
(4% SDS), 2 ml Glycerol (20% glycerol) (Carlo Erba), 1 ml - mercaptoethanol 
(10% -ME) (Merk), 0.05% Bromophenol Blue (BRB) (0.5 mg/ml) (Sigma) were 
dissolved in 10 ml de-ionized water. Solution was stored at -20C as aliquots of 1.5 
ml. 
2.1.5.8. Tank Buffer (Running Buffer) 
3 g tris (0.025 M Tris) (Merk), 14.4 g glycine (0.192 M Glycine) (Merk), 10 ml SDS 
solution (1 g/lt) (0.1% SDS) were dissolved in 1 lt de-ionized water. Solution was 
stored at 4C. 
2.1.5.9. Coomassie Blue Stain 
1 g CBB R-250 (0.1%) (Fluka), 500 ml methanol (50%) (Merk) and 100 ml acetic 
acid (10%) (Merk) were dissolved in de-ionized water up to 1lt. The solution was 
stored at room temperature.  
 
 
 29 
2.1.5.10. Gel Destain 
50 ml methanol (%5) and 100 ml acetic acid (10%) were mixed in 1 lt de-ionized 
water. The solution was stored at room temperature. 
2.1.6. Stock Solutions 
2.1.6.1. GTP Stock Solution 
200 mM GTP (Sigma) was dissolved in 1 ml de-ionized water and stored at -20C. 
2.1.6.2. DTT Stock Solution 
1 M DTT (Sigma) was dissolved in 1 ml de-ionized water and stored at -20C. 
2.1.6.3. Taxol Stock Solution 
10 mM Taxol (Paclitaxel, Sigma) was dissolved in DMSO (dimethyl sulfoxide) 
(Riedel-de Haen) and stored at -20C. 
2.1.6.4. Acrylamide Stock Solution 
1 M acrylamide was dissolved in 50 ml de-ionized water and stored in the dark, at 
4°C. 
2.1.7. Phosphocellulose Resin 
Cellulose Phosphate Cation Exchanger (Whatman) was used for ion-exchange 
column preparation. 
2.1.8. Solutions for Electron Microscopy 
2.1.8.1. Pioloform Solution 
250 mg pioloform (Agar Scientific) was dissolved in 100 ml chloroform (Merk) and 
stored at 4°C, in the dark. 
2.1.8.2. Gluteraldehyde 
40 μl % 25 Gluteraldehyde (Merk) was mixed with de-ionized water to make 4 % 
(v/v) and stored at room temperature. 
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2.1.8.3. Uranyl Acetate Solution  
Uranyl acetate (Sigma) was dissolved in de-ionized water as %2 (w/v). Dye solution 
was stored in dark at room temperature.  
2.1.9. Protein Marker 
Benchmark Prestained Protein Ladder (Gibco) was used as a standard to analyze the 
SDS-PAGE gels. It consists of 10 proteins ranging in molecular weights of 10, 15, 
20, 30, 40, 60, 70, 90, 130, and 220 kDa.  
2.1.10. Lab Equipments 
Autoclave                                            : 2540 ML benchtop autoclave, Systec GmbH  
                                                               Labor-Systemtechnik. 
         : NuveOT 4060 Vertical Steam Sterilizer,  
                                                               Nuve. 
Balances                                    : Precise BJ 610C, order# 160-9423-050, 
                                                        Presice Instruments AG Dietikon. 
                                                   : Precise XB 220A, order# 320-9204-001, 
                                                       Presice Instruments AG Dietikon. 
Centrifuges                                : Avanti J-30I, Beckman Coulter. 
                                                    : Optima LE 80 K, Beckman Coulter. 
                                                   : Optima Max, Beckman Coulter. 
                                                  : Microfuge 18, Beckman Coulter. 
                                                            : Allegra 25R, Beckman Coulter. 
Centrifuge rotors                    : MLA 80, Beckman Coulter. 
                                                   : JLA-16250, Beckman Coulter. 
                                                   : 70Ti, Beckman Coulter. 
                                                            : TS-5.1-500, Beckamn Coulter. 
Deep freezes and refrigerators         : Heto Polar Bear 4410 ultra freezer, JOUAN 
                                                             : Nordic A/S, catalog# 003431. 
                                                             : 2031 D deep freezer, Arçelik. 
                                                             : 1061 M refrigerator, Arçelik. 
Electron Microscope                          : Jeol Jem 1011. 
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Electrophoresis equipments             : EC 120 Mini Vertical Gel System, Thermo  
                                                              EC. 
Fluorescence Spectrometer              : LS-50, Perkin Emler. 
Fraction Collector                            :  Model 2110, Bio-Rad. 
Gel documentation system               : UVIpro GAS7000, UVItech Limited. 
Gel Dryer                                           : Bio Rad Model 583  
Glassware                                          : Technische Glaswerke Ilmenau GmbH. 
Grids                                                 : 300 mesh size copper grids, Sigma. 
Homogenizator                                 : Potter S, B. Braun Biotech International 
Ice Machine                                      : AF 10, Scotsman. 
Incubator                                           : EN400, Nuve. 
Laminar Flow Cabinet                    : Ozge. 
Magnetic stirrer                                : AGE 10.0164, VELP Scientifica srl. 
                                                            : AGE 10.0162, VELP Scientifica srl. 
Microwave                                        : MD582, Arçelik. 
Peristaltic pump                               : Econo Pump, Bio-Rad. 
pH meter                                           : MP 220, Metler Toledo International Inc. 
                                                            : Inolab pH level 1, order# 1A10-1113, 
                                                              Wissenchaftlich-Technische Werkstätten 
                                                              GmbH & Co KG. 
Pipettes                                               : 0.1-2.5 μl, 500-5000 μl, Mettler Toledo. 
                                                            : 10 μl, 20 μl, 200 μl, 1000 μl, Gilson. 
Pipette Tips                                        : 1-1000 μl, 1-200 μl, Axygen. 
                                                            : 1-10 μl, Molecular Bioproducts.  
Power suply                                       : EC 250-90, E-C Apparatus. 
Pure water systems                           : USF Elga UHQ-PS-MK3, Elga Labwater. 
Shaker                                                : Heidolph, Duomax 1030 
Spectrophotometers                          : DU530 Life Science UV/Vis, Beckman. 
                                                             : UV-1601, Shimadzu Corporation. 
                                                             : Lambda 25 UV/Vis, Perkin Emler. 
Spectrophotometer cuvettes             : Delta 
Test Tubes                                          : 1.5 ml tubes, Eppendorph. 
Vacuum Pump                                   : 262 BR, Bio-Rad. 
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Vortexing machine                            : Reax Top, product# 541-10000, Heidolph2.2. 
Water bath                                         : Memmert.  
2. 2. Methods 
2.2.1. Tubulin Purification 
 One bovine brain was collected and weighed as approximately 250 g  
 The brain was  kept on ice all the time, cerebellum and meninges were 
removed  
 The brain was cut with scissors 
 For each 100 g of brain, 75 ml PM-4M buffer containing 1 mM PMSF and 1 
mM DDT were added into stainless steel blender and mixed 
 The homogenate was centrifuged with Beckman Avanti J-30I centrifuge, 
JLA-16250 rotor, 250 ml tubes at 30,000xg and 4°C for 30 minutes 
 Supernatants were collected and centrifuged with Beckman Optima LE80K 
centrifuge, 70Ti rotor, 35 ml tubes, at 183,960xg (50,000 rpm) and 4°C for 
40 minutes 
 Supernatants were collected as the total volume (V1)  
 200 mM GTP was added and resulting mixture was incubated at 37° C for 30 
minutes 
 The mixture was centrifuged with  Beckman Optima LE80K centrifuge, 70Ti 
rotor, 26.3 ml tubes, at 183,960xg (50,000 rpm) (and Beckman Optima Max 
Ultracentrifuge, MLA 80 rotor, 10 ml tubes, at 184,262xg (60,000 rpm) at 
37° C for 30 minutes 
 Supernatants were decanded and pellets were taken onto ice and resuspended 
with 0.25xV1 ml of 1xPM buffer containing 1 mM PMSF and 1 mM DDT 
 The resuspended solution was homogenized with Potter S Homogenizator on 
ice and chilled on ice for 30 minutes 
 The homogenate was centrifuged with Beckman Optima Max 
Ultracentrifuge, MLA 80 rotor, 10 ml tubes, at 184,262xg (60,000 rpm) and  
4° C for 30 minutes 
 The supernatants were collected and named as V2 
 Equal volume (V2) of PM-8M buffer was added; total volume= 2xV2 
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 1 mM PMSF, 1 mM DDT and 2 mM GTP were added into total volume 
 Mixture was incubated at 37° C for 30 minutes 
 Mixture was centrifuged with Beckman Optima Max Ultracentrifuge, MLA 
80 rotor, at 184,262xg (60,000 rpm) and 37° C for 30 minutes 
 Supernatants were decanded and pellets were resuspended with 0.25x V2 ml 
of PM buffer 
 The resuspended solution was homogenized homogenizator on ice and 
incubated at 4° C for 30 minutes 
 The homogenate was centrifuged with Beckman Optima Max 
Ultracentrifuge, MLA 80 rotor, at 184,262xg (60,000 rpm) and 4° C for 30 
minutes 
 Supernatants were collected, named as semipurified tubulin and kept at -80°C 
as aliqoats 
 The concentration of protein was measured by Bradford Assay 
2.2.1.1. Bradford Assay 
 14.5 mg BSA was dissolved in 10 ml de-ionized water 
 Stock standart solutions were prepared as 20 μg/ml, 40  μg/ml, 60 μg/ml, 80 
μg/ml, 100 μg/ml, 120 μg/ml, 140 μg/ml, 160 μg/ml, 180 μg/ml, 200 μg/ml, 
220 μg/ml, 240 μg/ml, 260 μg/ml, 280 μg/ml and 300 μg/ml 
 From each stock standart  solution, 100 μl was added to tubes for standart 
preparation 
 Then 900 μl Bradford reagent was added into each tube (total 1 ml) 
 Sample preparation: sample amount was completed up to 100 μl with de-
ionized water 
 Then 900 μl Bradford reagent was added to each tube (total 1 ml) 
 The absorbance was measured at 595 nm with spectrophotometer 
2.2.1.2. Further Tubulin Purification 
Whatman Phosphocellulose Ion-Exchanger Column Preparation 
 The volume of glass column was measured and named as V 
 V/4 g of phosphocellulose resin was weighed and  put into a baker 
 25xV/4 ml 0.5 M NaOH  was added and stirred kindly, and left for 5 minutes 
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 The supernatant was decanded and washed with de-ionized water until the 
filtrate pH was 11.0 or below 
 25xV/4 ml 0.5 M HCl  was added and stirred gently, and left for 5 minutes 
 The supernatant was decanded and washed with de-ionized water until the 
filtrate pH was 3.0 or above 
 The supernatant was decanded completely and  25xV/4 ml 1x PM buffer was 
added 
 The pH was adjusted to 6.9 with NaOH 
 The resin was poured into the column 
 When all slurry was added, the cap of the column was attached 
 1x PM buffer was run through the column until the column bed height was 
constant 
 150 ml 1x PM buffer containing 0.1 mM GTP and 2 mM DDT was run 
through the column 
 The pH of the eluate was checked to be 6.9 
 The column was left overnight at 4° C 
 All the steps were completed at 4° C 
Further Tubulin Purification Through Column 
 The fraction collector was attached with peristaltic pump connected to the 
outlet of the column 
 Proper amount of semipurified tubulin solution was loaded to the column 
 Approximately V/2 ml of 1x PM buffer was passed through the column with 
the flow rate of 2.5 ml/min 
 1 to 12 fractions were collected as 2.5 ml and rest of the fractions were 
collected as 0.6 ml 
 10 μl samples were taken from each fraction and analyzed by Bradford Assay 
to determine which fractions contained protein 
 The fractions containing protein were pooled and the concentration was 
measured by Bradford Assay 
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2.2.1.3. Elution of MAPs from Phosphocellulose Column 
 After tubulin proteins were obtained, microtubule-associated proteins were 
eluted from the column. 
 200 ml 1X PM buffer containing 1 M NaCl was run through the column and the 
fractions were collected. 
 10 μl samples were taken from each fraction and analyzed by Bradford reagent 
to determine which fractions contained protein. 
 To determine the MAP fractions 7% SDS-PAGE gel was run and the fractions 
containing protein were pooled. 
 Then MAPs were centrifuged with Beckman Allegra 25R, TS-5.1-500 rotor, 
Amicon-Centriplus centrifugal filter devices at 1396 x g, at 4C for several 
hours. 
 The filtered buffer was decanded and centrifugation was continued until MAPs 
were concentrated to 1/5 of its starting volume. 
 MAPs were washed three times with 1X PM buffer to decant from salt. 
 Then MAPs were collected by centrifugation. 
 The concentration of MAPs was measured by Bradford Assay. 
2.2.2. Sedimentation Assay 
2.2.2.1. Semipurified Tubulin Reaction Conditions: 
1- 5 μM semi-purified Tb + 1 mM GTP (37°C–60′)  
2- 5 μM semi-purified Tb + 1 mM GTP (37°C–60′)  → 100 mM Acr (37°C–30′) 
3- 5 μM semi-purified Tb + 100 mM Acr (37°C–60′)  →  1 mM GTP (37°C–30′) 
4- 5 μM semi-purified Tb + 1 mM GTP + 100 mM Acr (37°C–60′)   
5- 1 mM GTP + 100 mM Acr (37°C–60′) → 5 μM semi-purified Tb (37°C–30′) 
2.2.2.2. TMT preparation: 
 10 μM semipurified tubulin, 1 mM GTP, 100 μM Taxol were mixed in AB 
buffer in a volume of 100 μl 
 Mixture was incubated at 37° C for 30 minutes  
 Microtubule sedimentation assays were carried out in AB buffer.  
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 In a reaction volume of 100 μL, tubulin (5 μM final) or taxol-stabilized 
microtubules (TMT) were incubated with or without GTP (1 mM) in the 
presence of acrylamide (100 mM).  
            1- 5 μM TMT  
            2- 5 μM TMT + 100 mM acrylamide 
 Control reactions contained no acrylamide.  
 After incubations for 30 and 60 minutes at 37° C, reactions were centrifuged 
at 50,000xg (127,960 rpm) for 30 minutes at 37° C.  
 The supernatants were  transfered into tubes containing equal amounts of 2x 
SDS sample buffer, and the pellets were resuspended in 100 uL of 1x SDS 
sample buffer.  
 Supernatant and pellet fractions were then analyzed by SDS-PAGE.  
 For quantitative analysis, the amount of supernatant and pellet samples 
loaded onto the gels was optimized to ensure a linear relationship between 
the amount of protein loaded and the intensity of the Coomassie blue stained 
protein bands.  
 The amount of MT proteins in the supernatant and the pellet fractions was 
quantified by mesuring the protein band intensities relative to standarts with 
documentation and analysis system. 
 Prior to performing MT polymerization experiments, in particular reactions 
tubulin was incubated for 30 minutes with taxol and GTP to be assembled 
into MTs. 
2.2.2.3. SDS-PAGE 
 Supernatants and pellets were separated 
 For each 100 μl of supernatant, 100 μl 2x sample buffer was added and 
mixed with vortex 
 For each pellet, 100 μl 1x sample buffer was added and mixed with vortex 
 5 μl samples from pellet solutions and 10 μl samples from supernatant 
solutions were loaded onto SDS-PAGE gels using micropipette and loading 
tips 
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Assembly of Gel Apparatus 
 Glass plates and spacers were cleaned with ethanol 
 They were assembled in gel holder on casting stand  
 Upper and lower screws were tightened and bottom edges of gel plates were 
checked 
 Smaller plate was marked 1.5 cm from top 
%10 Running (Separating) Gel Preparation 
 1.67 ml %30 acrylamide, 1.25 ml 4x running gel buffer, 1.97 ml de-ionized 
water, 50 μl %10 SDS, 30 μl %10 APS and 10 μl TEMED were mixed and 
poured between the glass plates up to the mark 
 When the gel was polymerized, the top of the gel was rinsed with tank buffer 
 Remaining water was absorbed with fitler paper 
%4 Stacking Gel Preparation 
 0.27 ml %30 acrylamide, 0.5 ml 4x stacking gel buffer, 1.9 ml de-ionized 
water, 20 μl %10 SDS, 10 μl %10 APS and 5 μl TEMED were mixed and 
poured onto the running gel up to the top of the front plate 
 A comb was placed into the stacking gel quickly 
 Gel was left for polymerization 
 After polymerization the comb was removed carefully 
 Lanes were washed with tank buffer and dried with filter paper 
2.2.3.4. Loading and staining of the polyacrylamide gel 
 5 μl samples from pellet solutions and 10 μl samples from supernatant 
solutions were loaded onto polyacrylamide gels using micropipette and 
loading tips 
 Gel was run at 200 mV for 45 minutes with power suply 
 The glass plates were separated and the gel was placed in Coomassie Blue 
stain in a clean box 
 The gel was microwaved at 750 Watt for 40 second 
 Then the gel was placed on shaker for 2 minutes 
 The stain was poured off and the gel was rinsed with gel destain  
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 The gel was covered with gel destain and microwaved at 750 Watt for 50 
second 
 The gel was placed on shaker for 15 minutes 
 Then destain was poured off and replaced with fresh destain solution 
 The gel was left overnight on shaker 
 The gel was dried with gel drier for storage 
 After scanning of dry gel, it was analysed with gel documantation system  
2.2.4. Fluorescence Spectrometer 
Reaction conditions: 
1- 10 μM tubulin + 1 mM GTP 
2- 10 μM tubulin + 1 mM GTP + 100 mM acrylamide 
 
 Spectrometric mesurements were performed in AB buffer using the Model 
LS-50 spectrometer of Peklin-Elmer, equipped with temperature controller.  
 In reaction volume of 3 mL, tubulin (5-10 μM) protein was mixed with 
acrylamide (100 mM) and/or GTP (1mM).  
 Samples were excited at 295 nm and variation in the fluorescence spectra and 
emission intensity of the tryptophan residues in tubulin were monitored at 
336 nm as a function of polymerization time during 1 hour incubation at 
37°C. 
2.2.5. Malachite Green Procedure 
2.2.5.1. Color reagent preparation:  
 Concentrated sulfuric acid, H2SO4 (60 ml, d = 1.84 g/liter) was slowly added 
to 300 mL of water.  
 The solution was cooled to room temperature  
 0.44 g of malachite green was added  
 The resulting orange solution was stable for at least 1 year at room 
temperature.  
 On the day of use, 0,3 g ammonium molybdate and 22 μl Tween-20 were 
added to 10 ml of the dye solution. 
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2.2.5.2. Protein reaction mixture preparation: (10 μM ptb and 10 mM GTP) 
 First, 100 mM GTP (stock: 200 mM) was exposed to 100 mM acrylamide 
(stock:1000 M) 
           1- GTP alone mix= 50 μl GTP + 50 μl AB buffer  
           2- GTP + acrylamide mix= μl GTP + 10 μl acylamide + 40 μl AB buffer 
 These two reactions were incubated at 37° C for 30 minutes 
 10 μM purified tubulin (stock: 14 μM) was exposed to these two mixtures 
(final GTP and acrylamide concentrations became 10 mM) 
           1- 643 μl ptb + 90 μl GTP alone mix + 167 μl AB buffer = 190 μl 
           2- 643 μl ptb + 90 μl GTP + acrylamide mix + 167 μl AB buffer = 190 μl 
 These two reactions were incubated at 37° C for 30 minutes 
2.2.5.3. Deproteinization and Phosphate determination:  
 Deproteinization with perchloric acid  was performed by adding 1 volume of 
70 % (w/w) perchloric acid, HClO4 to 22 volume of protein reaction mixture 
(40.9 μl HClO4 + 900 μl protein solution) 
 After standing for 10 minutes at 0° C, the mixture was centrifuged for 2x 3 
minutes at 13,000xg (~14,000xrpm) and the supernatant was used for 
phosphate determination  
 The color reagent (200 μl) was mixed with 800 μl of the supernatant and 
incubated for 10 minutes at room temperature  
 The absorbance at 630 nm was measured using spectrophotometer  
 Blanks contained AB buffer and the color reagent (800 μl AB buffer + 200 μl 
color solution) 
 Note: Absorbance measurements were never exceeded 10 minutes. 
2.2.6. Electron Microscopy 
2.2.6.1. Membrane coating of grids: 
 0.25 gram Pioloform was dissolved in 100 ml chloroform and incubated at 
4°C in a dark bottle for 10 days 
 Grids were rinsed with absolute alcohol and then chloroform and left for air 
drying 
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 A clean glass block was plunged into pioloform solution and left for 
aproximately 2 minutes for air drying 
 Pioloform membrane on the glass block was cut from the sides of the glass 
block 
  Glass block was plunged into water so that pioloform membrane swimmed 
on water 
 Then grids were put onto membrane as their shiny sides on top 
 A glass slight was put onto pioloform membrane with a 45° angle   
 Glass slight with grids coated with pioloform membrane was put into a glass 
petri and incubated at 37°C for 24 hours 
2.2.6.2. Reaction Conditions: 
Control 1: 10 μM semi-purified tubulin + 5 mM GTP + 100 μM Taxol 
Control 2: 10 μM semi-purified tubulin + 5 mM GTP  
Reaction 1a: 10 μM semi-purified tubulin + 5 mM GTP + 100 μM Taxol + 100 mM 
acrylamide 
Reaction 1b: 10 μM semi-purified tubulin + 5 mM GTP + 100 mM acrylamide 
 All reactions were completed up to 100 μl with AB buffer in 1.5 ml 
eppendorf tubes 
 The tubes were incubated at 37° C in water bath for 1 hour 
 They were centrifuged with Beckman Optima Max Ultracentrifuge, MLA-80 
rotor, at 127,960xg (50,000 rpm), 37° C for 30 minutes 
 The supernatants were decanded  
 20 μl %4 glutharaldehyde was added onto pellets and left for 15 minutes 
 Pellets were resuspended with micropipette one-two times gently 
 Grids were plunged into tubes and waited for 20 seconds 
 Then grids were washed by plunging into distelled water three times 
 Grids were left for air-dry for 30 minutes and stained 
2.2.6.2. Staining: 
 One drop of %2 uranylacetate for each grid was put onto parafilm 
 Grids were placed on drops upsite down and left for 2 minutes 
 Grids were washed by plunging into distilled water two times 
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 Excess water was removed with filter paper 
 Grids were left for air-dry 
 Grids were analysed with transmission electrone microscope 
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3. RESULTS AND DISCUSSION 
Since the announcement by a Swedish research group in April 2002 regarding the 
presence of acrylamide in potato and grain-based foods  such as potato chips and 
breakfast cereals, there has been a renewed interest in the toxic actions of this 
chemical. Acrylamide is a prototypic chemical in elucidating molecular mechanisms 
leading to distal axonopathy. Elucidation of the mechanisms is essential to 
prevention, treatment and repair of neurotoxic damage produced by acrylamide and 
similar agents. In addition to this, identification of toxicants’ mechanisms provides 
insight into molecular mechanisms of human diseases. These agents are also useful 
tools in understanding of normal cellular function and structural elements of the 
cells. 
Because of the abundance of cytoskeleton and its many related functions in the 
nervous system, it has been difficult in many cases to identify whether alterations in 
cytoskeleton represent primary toxic effects or secondary effects caused by other 
changes in the cell.  
The morphological hallmark of this axonopathy is considered to be “axon 
degeneration”, which begins as multifocal  paranodal swellings of preterminal distal 
fibers. Axonal swellings contain an abundance of neurofilaments, tubulovesicular 
profiles and degenerate mitochondria. In addition, it has been shown that 
microtubule poisons adversely affect axonal transport. Several studies have 
identified reduced delivery of macromolecules to the distal axon by acrylamide.  In 
this study, we have studied in vitro effects of acrylamide on microtubules purified 
from bovine brain to investigate the molecular mechanism of neurotoxic damage. 
Tubulin obtained by two cycles of polymerization-depolymerization and ion-
exchange chromatography was investigated for polymerization dynamics in the 
presence of acrylamide using different methods. 
In sedimentation assays, purified or semi-purified tubulin was treated with 
acrylamide under different conditions to show the effect of acrylamide on 
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polymerization. In addition, taxol-stabilized microtubules (TMTs) were exposed to 
acrylamide  to show the effect of acrylamide on stabilized microtubules. Also, GTP 
exposed to acrylamide was used in sedimentation assay to show whether acrylamide 
had an effect on GTP.  
Structural transitions such as polymerization cause an increase in emission spectrum 
of fluorescence. Fluorescence spectrometric measurements were performed to show  
whether acrylamide causes inhibition of polymerization of tubulin dimers into 
microtubules in the presence or absence of GTP. 
Since GTP is hydrolyzed into GDP and Pi during microtubule polymerization, and 
the produced Pi is well-proportioned to the number of tubulin subunits which join to 
the microtubule structure, we measured the produced Pi amount during microtubule 
polymerization using malachite green. Malachite green reacts with 
phosphomolybdate, and this reaction results in the appearance of an intense 
absorbance band at 620-650 nm. 
Then, to examine the structures that pelleted in the sedimentation assay and 
fluorescence spectrometer, tubulin samples were observed by  Transmission Electron 
Microscopy. Effects of acrylamide on microtubule structure were examined.  
3.1. Tubulin Purification 
A fresh bovine brain was taken to the laboratory on ice immediately. The 
cerebellum, meninges and blood vessels were removed. The brain was weighed and 
homogenized. Then, the homogenate was subjected to repetitive cycles of 
polymerization-depolymerization. At the end of these cycles, tubulin proteins were 
purified as associated with microtubule associated proteins (MAPs) and this elute 
was called semi-purified tubulin. The protein concentration was measured by the 
Bradford protein assay using bovine serum albumin (BSA) as a standard.  
Afterwards, the pelleted solution from cycles of polymerization-depolymerization 
was further purified using phosphocellulose ion-exchange column to remove 
contaminating microtubule-associated proteins. Ion-exchange chromatography 
separates proteins based on their different charges. Since tubulin is charged 
negatively and MAPs are charged positively, MAPs remained attached to the resin in 
the column and tubulin passed through the column.  
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All the fractions collected from the column were analyzed qualitatively using 
Bradford reagent to examine the presence of tubulin. Coomassie Brilliant Blue G-
250 in Bradford reagent binds to tubulin and causes a change in the color of the 
protein solution. Therefore, fractions containing protein were pooled and called 
purified tubulin. To confirm the purity of tubulin, the fractions from different steps 
of purification were loaded to polyacrylamide gel (Figure 3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Polyacrylamide gel of purification steps. 1. column: protein marker. 2. column: semi-
purified tubulin with MAPs. 3. column: purified tubulin. 4. column: pure tubulin (%99) which was 
purchased from Cytoskeleton as a control marker. 
3.2. Elution of MAPs from phosphocellulose column 
Positively charged MAPs remained attached to the resin during elution of tubulin. 1 
M NaCl was run through the column to elute MAPs from the column. The eluted 
buffer containing MAPs was collected as fractions. Samples were taken from each 
fraction and analyzed qualitatively using Bradford reagent to detect the presence of 
proteins. Subsequently, samples from fractions containing protein were loaded  to 
polyacrylamide gel (Figure 3.2). 
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Figure 3.2. Polyacrylamide gel of MAPs fractions eluted from phosphocellulose column. 
3.3. Sedimentation Assay 
Microtubule sedimentation assay was used to evaluate the effect of acrylamide on 
polymerization dynamics of microtubules. Semi-purified and purified tubulin 
proteins (5 M)  were subjected to acrylamide (100 mM) in the presence or absence 
of GTP (1mM), and then subjected to centrifugation to separate unpolymerized 
tubulin in the supernatant from polymerized microtubule-containing pellet fractions. 
Semi-purified tubulin was exposed to acrylamide under different conditions shown 
below. The reason for choosing these different reaction conditions was to evaluate 
on which steps acrylamide had possible effects. Acrylamide was added into reactions 
at different steps to see whether the effect was on tubulin polymerization or 
polymerized microtubules, or both.  
1. Tubulin + GTP 
As a control reaction, tubulin was incubated with GTP at 37C to provide 
microtubule polymerization. 
2. Tubulin + GTP  Acrylamide 
To see the effect of acrylamide on previously polymerized microtubules, tubulin was 
incubated with GTP at 37C, then acrylamide was added and incubated at 37C. 
3. Tubulin + Acrylamide  GTP 
Tubulin before polymerization into microtubules (in the absence of GTP ) was 
treated with acrylamide at 37C and then GTP was added and incubated at 37C. 
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4. Tubulin + GTP + Acrylamide 
Tubulin, GTP, and acrylamide were altogether incubated at 37C, to see tubulin 
polymerization into microtubules due to GTP in the presence of acrylamide. 
5. GTP + Acrylamide  Tubulin 
GTP was exposed to acrylamide at 37C to see whether acrylamide has en effect on 
GTP. Then, tubulin was added and incubated at 37C.  
Afterwards, all reaction mixtures were centrifuged and separated as supernatant and 
pellet fractions. Samples from supernatants and pellets for each reaction were 
analyzed on polyacrylamide gel in the presence of tubulin standard samples (Figure 
3.3).  
 
Figure 3.3. Polyacrylamide gel of sedimentation assay with 5 M semi-purified tubulin, 1mM GTP 
and 100 mM acrylamide. 
1, 2, 3: Tubulin standards.  
4, 5: Control reaction (Tubulin + GTP) 
6, 7: 2. reaction (Tubulin + GTP  Acrylamide) 
8, 9: 3. reaction (Tubulin + Acrylamide  GTP) 
10, 11: 4. reaction (Tubulin + GTP + Acrylamide) 
12, 13: 5. reaction (GTP + Acrylamide  Tubulin). 
For the control reaction, pellet fraction was significant, and there was some tubulin 
in the supernatant fraction. In the second reaction, all tubulin proteins were observed 
in supernatant fraction indicating that acrylamide caused total depolymerization of 
microtubules when it was added onto GTP-polymerized microtubules. In the third 
reaction, a very little protein was observed in the pellet fraction, and the great 
majority of tubulin was in the supernatant fraction. These results indicate that  
acryalmide inhibited tubulin polymerization when incubated at 37°C, even if GTP 
was added into reaction mixture later on. In the 4. reaction, very  little protein was 
observed in the pellet fraction, and the great majority of tubulin was in the 
supernatant fraction. Although GTP was present in the reaction mixture, acrylamide 
effected tubulin and inhibited polymerization into microtubules. In the 5. reaction,  
all tubulin proteins were observed in the supernatant fraction indicating that 
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acrylamide caused total inhibition of polymerization of microtubules when GTP was 
incubated with acrylamide and then tubulin was added. The results of 4. and 5. 
reactions raised a question “Whether or not acrylamide has an effect on GTP?”. 
Therefore, we examined the effect of acrylamide on GTP by incubating GTP (100 
mM) with acrylamide (100 mM) at 37C, then tubulin was added to the reaction 
mixtures and incubated at 37C. This time acrylamide-GTP mixture was diluted (1 
mM final acrylamide and GTP concentration) before addition of tubulin to provide 
minumum or no effect of acrylamide on tubulin (Figure 3.4).  
                        
Figure 3.4. Polyacrylamide gel of GTP-ACR interaction reactions.  
1, 2, 3: Tubulin standards 
4, 5: Control reaction (GTP → Tubulin) 
6, 7: Reaction with acrylamide (GTP + Acrylamide → Tubulin) 
A decrease in pellet formation was observed in reactions containing acrylamide 
compared to control reactions. The difference between the two pellet fractions was 
significant. These results indicated that acrylamide also had an adverse interaction 
with GTP. We believe that depolymerizing effect was due to acrylamide-GTP 
interaction rather than acrylamide-tubulin interaction. Because when tubulin was 
added, acrylamide concentration was too low (1mM). During preliminary 
experiments, acrylamide did not show any depolymerizing effect or inhibition of 
polymerization at such low concentrations. 
Taxol-stabilized microtubules (TMTs) were also exposed to acrylamide to 
investigate the level of depolymerization effect of acrylamide. Tubulin proteins were 
incubated with GTP and taxol (a microtubule polymerizing agent) into reaction tubes 
to provide microtubule polymerization and stabilization of microtubules. Then, 
acrylamide was added into one of the reactions and incubated at 37C. The reaction 
mixtures were centrifuged. Supernatant and pellet fractions were separated and 
analyzed on polyacrylamide gel. 
TMT experiments were performed with both semi-purified tubulin and purified 
tubulin which was purchased from Cytoskeleton. In the experiment with pure tubulin 
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acrylamide showed significant depolymerization effect at 37°C, even though taxol 
was present (Figure 3.5).  
                                  
Figure 3.5. Polyacrylamide gel of the TMT reactions with pure tubulin purchased from Cytoskeleton.  
1, 2: Control reaction.  
3, 4: Reaction with acrylamide.   
In the experiments with semi-purified tubulin, pellet formation in reactions 
containing acrylamide was significantly less than control reactions indicating that 
acrylamide showed depolymerizing effect (Figure 3.6).   
                                 
Figure 3.6. Polyacrylamide gel of the TMT reactions with semi-purified tubulin.  
1, 2: Control reaction.  
3, 4: Reactions with acrylamide.  
These results indicated that acrylamide caused depolymerization of both purified and 
semi-purified microtubules. Although in control reactions all tubulin subunits did not 
polymerize and there were some protein in the supernatant fractions, the difference 
between the conditions containing acrylamide and no acrylamide was significant 
indicating partial depolymerization of microtubules due to acrylamide.  
3.5. Fluorescence Spectrometer 
Proteins contain three amino acid residues which may contribute to their ultraviolet 
fluorescence: tyrosine, tryptophan, and phenylalanine. Protein fluorescence is 
generally excited at the absorbtion maximum near 280 nm and fluorescence emission 
maxima range from 320 to 350 nm.  However, emission from phenylalanine is rarely 
observed because of small yield of phenylalanine in proteins. Therefore, the 
absorbtion of proteins at 280 nm is due to both tyrosine and tryptophan residues. At 
wavelenghts longer than 295 nm, the absorbtion is due primarily to tryptophan.  
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Tryptophan (intrinsic fluorophore) is the most highly fluorescent amino acid in 
proteins. The tryptophan residues of proteins generally account for about 90% of the 
total fluorescence from proteins. This natural fluorophore is highly sensitive to the 
polarity of its surrounding environment. Frequently, spectral shifts are observed as a 
result of several phenomena, such as binding of ligands, protein-protein association, 
and denaturation. Tryptophan fluorescence can be selectively excited at 295 to 305 
nm. The emission maximum of tryptophan in water occurs at 336 nm, and is highly 
dependent on polarity.  
There are eight tryptophan residues in a tubulin dimer. Changes in the fluorescence 
of  tryptophan residues can be used to monitor structural transitions. When 
microtubules are depolymerized, tryptophan residues are exposed to the aqueous 
solvent. However, polymerization of tubulin dimers causes holding of tryptophan 
residues within the 3D structure. This structural transition causes an increase in 
emission spectrum.  The fluorescence spectral properties of tubulin (or MTs) show 
differences in the presence or absence of depolymerizing agents. This illustrates the 
sensitivity of the spectral properties to the three-dimentional structure of the protein.  
In order to monitor effects of acrylamide on microtubule polymerization, we 
compared fluorescence intensities of tryptophan in the presence or absence of 
acrylamide with or without GTP. Tryptophan gives maximum emission intensity at 
336 nm when excited at 295 nm. These findings were also confirmed in our primary 
measurements (Figure 3.7). 
Figure 3.7. Graphic of fluorescence spectrometer showing maximum emission intensities at 336 nm 
and exitation at 295 nm. 
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In the experiments without GTP, acrylamide caused a decrease in the emission 
spectrum and scattered light increased compared to control reaction. Furthermore, 
corrected emission values were similar in the absence and presence of acrylamide 
(Figure 3.8 and Figure 3.9). 
 
Figure 3.8. Graphics of fluorescence spectrometer showing emission intensities versus  time. In the 
absence of GTP A) without acrylamide and B) with acrylamide.  
 
 
 
Figure 3.9. Graphics of fluorescence spectrometer for the reactions with acrylamide in the absence of 
GTP. 
A) Emission intensities versus time.  
B) Scattered light versus time.  
C) Corrected emission intensities versus time.  
In the absence of GTP, the presence of acrylamide caused a significant increase in 
the scattered light at 295 nm, and emission intensity at 336 nm decreased 
significantly  compared to control reaction. In addition, the difference between the 
corrected emission intensities was very little that it could be ignored. Corrected 
emission intensity is obtained by division of emission intensity by scattered light. 
A) B) 
A) B) C) 
A) B) 
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Corrected spectra are needed for calculation of quantum yields. Since scattered light 
is affected by the molecules in the solution, presence of acrylamide might increase 
the scattered light relatively, and emission intensity might decrease due to hit of 
molecules with each other hence loss of the energy in the presence of acrylamide. 
However, when the corrected emission spectra were evaluated, approximately no 
change was observed due to the absence of polymerization in the absence of GTP.  
In the experiments with GTP, acrylamide caused an evident increase in the scattered 
light, and the emission spectrum decreased significantly compared to control 
reaction. Furthermore, acrylamide caused a decrease  in corrected emission values 
(Figure 3.10 and Figure 3.11) 
 
Figure 3.10. Graphics of fluorescence spectrometer showing emission intensities versus  time. In the 
presence of GTP:  
A) Without acrylamide  
B) With acrylamide  
 
Figure 3.11. Graphics of fluorescence spectrometer belonging the reaction with acrylamide in the 
presence of GTP: 
A) Emission intensities versus time.  
B) Scattered light versus time.  
C) Corrected emission intensities versus time.  
A) B) 
A) B) C) 
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In the presence of GTP,  acrylamide caused an evident increase in the scattered light 
which was related to the molecule amount in the solution. However, the reduction in 
the emission spectrum observed was due to acrylamide. Furthermore, corrected 
emission value reduced with acrylamide compared to control reaction. Since 
emission spectrum is indicative of transition into 3D structure, which indicates 
polymerization, we suggest that acrylamide inhibited the polymerization of  tubulin 
subunits into microtubules. The results without GTP also support this idea, since no 
polymerization is expected in  the absence of GTP 
3.6. Malachite Green Procedure 
Highly sensitive methods for phosphate measurement are based on the change in the 
absorbtion spectra of basic dyes upon complex formation with phosphomolybdic 
heteropolyacid. Malachite green is the most frequently used basic dye, and its 
reaction with phosphomolybdate results in the appearance of an intense absorbance 
band at 620-650 nm. Numerous procedures for phosphate measurement with 
malachite green have been proposed. The most versatile version involve the addition 
of one color reagent that combines all analytical components. They are, however, 
less sensitive because of extensive dilution of sample with the color reagent. Much 
higher sensitivity has been reported for the procedures which involve several 
pipetting steps because they permit a sample-to-reagent ratio greater than unity. A 
common drawback of the majority of the published procedures is that they require a 
filtration step during color reagent preparation because of the low solubility of 
malachite green.  
In 1988, Baykov et al. described a modified malachite green method combining all 
necessary reagents in one concentrated solution for phosphate determination. In 
addition to this, in 1991, Geladopoulos et al. modified this method one more time by 
adding a deproteinization step. We preferred this second modified method because it 
is highly sensitive, requires only one pipetting step, eliminates the problem of dye 
solubility and does not cause acid hydrolysis of phosphate groups by using protein 
stabilization with sodium dodecyl sulfate instead of stabilization with acid solutions. 
The procedure is based on the finding that the dye is easily soluble  and stable in the 
presence of 6 N acid. The addition of Tween-20 is required to stabilize the dye-
phosphomolybdate complex at phosphate concentrations above 10 M. Proteins 
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must be removed or stabilized prior to Pi determination by sodium dodecyl sulfate. 
The time of color development at 25°C is about 3 minutes.    
We used the colorimetric Pi microarray to determine GTPase activity in microtubule 
polymerization reactions. Since GTP is hydrolyzed and Pi is released during 
microtubule polymerization, we investigated whether there is a difference in released 
Pi amount due to the presence of acrylamide.  
Firstly, color reagent containing malachite green, sulfuric acid, Tween-20 and 
ammonium molybdate was prepared. Two reaction mixtures were prepared: one 
containing GTP, and one containing GTP and acrylamide. Reactions were incubated 
at 37°C. Then, reaction mixtures were diluted and tubulin was added, then incubated 
at 37°C. Following deproteinization step with perchloric acid, color reagent was 
added into tubes and absorbances were measured at 630 nm.  
                
0
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Phosphate determination by malachite 
green
 
Figure 3.12. Graphic of phosphate determination using malachite green. First column indicates the 
absorbance of the control reaction containing GTP and tubulin. Second column indicates the 
absorbance of the reaction containing GTP, tubulin and acrylamide. 
We observed a significant decrease in the absorbance of the reaction containing 
acrylamide compared to the control reaction (Figure 3.12). Since GTP is hydrolyzed 
into GDP and Pi during microtubule polymerization, and the produced Pi is well-
proportioned to the number of tubulin subunits which join to the microtubule 
structure. These results indicated inhibition of tubulin polymerization into 
microtubules due to acrylamide.  Acrylamide may also have adverse effects on GTP 
in addition to effects on tubulin. However, further analysis is needed with other 
GTP-related reactions.  
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3.7. Electron Microscopy 
Electron microscopes have provided a great knowledge about detailed structures of 
microtubules. To examine the structures that pelleted in the sedimentation assay and 
fluorescence spectrometer, tubulin samples were observed by Transmission Electron 
Microscopy (TEM). In this technique, an electron beam passes through the specimen 
and results in different light/dark patterns on the specimen. The darker areas 
represent denser electron regions whereas the lighter areas represent the regions with 
fewer electron density.  
In these experiments, 10 M tubulin or 10 M TMTs were incubated with 5 mM 
GTP and 100 mM acrylamide at 37°C for 1 hour. Control reactions were incubated 
without acrylamide. In electron microscopy experiments, GTP concentration was 
increased to 5 mM to stabilize microtubules against the harsh steps of the method. 
Then, reactions were centrifuged and pellet fractions were subjected to 
gluteraldehyde for 15 minutes. The samples were adsorbed to pioloform coated 
cupper grids and negatively stained with uranyl acetate.   
In the primary experiments without taxol, microtubule structures were hard to 
observe (perhaps due to harsh conditions). For this reason, we chose to stabilize the 
microtubule structures with taxol. In the control reactions containing tubulin, GTP 
and taxol, an abundance of intact microtubules was observed in addition to free 
tubulin subunits (Figure 3.13). 
 
Figure 3.13. Transmission electron micrographs of control reaction1; Tubulin + GTP + Taxol. A) 
50,000x and B) 100,000x 
In the reactions containing taxol-stabilized microtubules and acrylamide, acrylamide 
changed the microtubule structure. Instead of intact microtubules, relaxed, 
A) B) 
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disintegrated structures which started to depolymerize at one end were observed  
(Figure 3.14).  
 
 
 
Figure 3.14. Transmission electron micrographs of reaction 1a; Tubulin + GTP + Acrylamide + 
Taxol. A) 25,000x, B) 50,000x, C) 25,000x and D) 50,000x 
Taxol binds to tubulin subunits and stabilizes the microtubule structure. Therefore, 
intact microtubules were observed in the control reaction containing taxol. 
Furthermore, the presence of taxol resulted in microtubule assembly, and addition of 
acrylamide modified these microtubule structures such that in their natural structure. 
Instead, relaxed, disintegrated (dissolved) and curved structures were seen, and, 
microtubules started  to depolymerize at one end (Figure 3.14). These results suggest 
that acrylamide is a strong depolymerizing agent which can affect even the taxol-
stabilized microtubules.   
 
 
 
 
 
 
A) B) 
C) D) 
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4. CONCLUSION 
Since acrylamide is a neurotoxicant disrupting axonal transport in neurons, and 
microtubules are one of the major elements of axonal transport, in this study, we 
investigated the effects of acrylamide on microtubule dynamics. Our results showed 
that acrylamide causes depolymerization of microtubules. Also acrylamide inhibits 
polymerization of tubulin dimers into microtubules. In addition, our results 
demonstrated that acrylamide is a strong depolymerizing agent which can 
depolymerize even the taxol-stabilized microtubules. Acrylamide may also have 
effects on microtubule polymerization through GTP. However, further analysis is 
needed with other GTP-related reactions. As a conclusion: one important mechanism 
of acrylamide’s in exhibiting its neurotoxic effects is by disrupting microtubule 
dynamics. 
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